Therapeutics Articles
The effectiveness of this controversial therapy in treating musculoskeletal disorders and other arthritic conditions is uncertain due to mixed results. Nevertheless, the PRP industry is booming.
It is now well-established that prehospital transfusion of plasma, with its balanced mix of coagulation proteins, counters the hemodilution and progressive derangement of hemostatic mechanisms caused by crystalloid-based resuscitation, improving the changes of survival in severely bleed trauma victims.
In the realm of healthcare and pharmaceuticals, orphan drugs have emerged as a beacon of hope for individuals suffering from rare diseases. With new technology and AI-driven analytics as drivers, these once-niche therapies are rapidly taking center stage.
Precise, personal treatment is the way of the future. Here's how experts are using genetic sequencing to forge a revolutionary new way of practicing medicine.
Renewed interest and research in psychedelic compounds is giving formerly illicit drugs a 21st century image makeover. Are they really breakthrough solutions for treatment-resistant conditions such as depression and PTSD? At this point, the data looks promising.
For decades, respiratory syncytial virus (RSV) has defied the best efforts of vaccine makers to bring it to heel, until now.
This growing field of intervention-based therapeutics promises to enhance patient health and make healthcare more proactive.
The shortcomings of AAT augmentation therapy for AATD are currently the targets of a diverse range of new investigational therapies.
While a cure for Alzheimer’s remains elusive, new diagnostic tools and treatment options are improving patient quality of life.
Exciting new developments in gene therapy and genome editing show promise for treating a variety of genetic diseases.
RSV infections account for a large share of U.S. hospitalizations for lower respiratory tract disease due in large part to a lack of immunization and prophylactic therapies, but new developments and cutting-edge therapies may soon become standard medical practice.
While acetylcholinesterase inhibitors, corticosteroids and thymectomy are generally considered first-line therapies for MG, many patients additionally require proven immunosuppressive therapies (ISTs) such as azathioprine, cyclosporine/tacrolimus or mycophenolate mofetil, or immunomodulatory therapies, including intravenous immune globulin (IVIG) or plasma exchange (PLEX).
